Replay available

STAAR Surgical Company (STAA) Q1 2025 Earnings Call

STAAR Surgical Company (NASDAQ: STAA) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Wed, May 7, 2025 at 5:15 PMendedReplay
STAAR Surgical Company (STAA) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Brian Moore

Vice President of Investor Relations

Steve Farrell

Chief Executive Officer

Warren Faust

President and Chief Operating Officer

Deborah Andrews

Interim Chief Financial Officer

Tom Stefan

Analyst

Ryan Zimmerman

Analyst, BTIG

Anthony Petroni

Analyst, Mizuho Group

Simran Kaur

Analyst, Wells Fargo

Patrick Wood

Analyst, Morgan Stanley

Replay transcript excerpt

Greetings and welcome to the STAR Surgical first quarter 2025 learnings call and webcast. As a reminder, this event is being recorded today, Wednesday, May 7th, 2025. During today's presentation, all parties will be in a listen-only mode. If you need any assistance during this time, please press star and zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touch-tone phone. To withdraw your question, please press star, then two. I would now like to introduce your host, Brian Moore, Vice President of Investor Relations with Star Surgical. Please go ahead. Thanks, Operator. Good afternoon, and thank you for joining us. On the call today are Steve Farrell, CEO of Warren Faust, President and COO, and Deborah Andrews, Interim CFO. Earlier today, we reported our first quarter results via press release and Form 8K. We've posted our earnings release and presentation to our investor website at investors.star.com. Today's call is scheduled for one hour and will include Q&A for publishing analysts. Webcast participants can also send questions for today's Q&A session to ir.com. Before we get started, I want to remind you that during today's discussion, we will be making forward-looking statements. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. I encourage you to read the disclaimers in today's release, the presentation, as well as disclosures in our filing with the SEC. Except as required by law, SAR assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes. In addition, during today's discussion, we will referenc...

More from Staar Surgical Company